APOTHEEK LIBRA
ActiveSummary
APOTHEEK LIBRA has been active since 1995 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €277,160 and a net result of €53,454. Equity remains stable across the filed financial years (±0% per year). Its solvency ranks better than 38% of 5,019 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
03-09
NBB filing
Annual accounts filed
financial year 2025 · full format · 34 days late
2025
31-12
Financial
Weakest financial yearnet €53,454 ▼36%
Net result drops to €53,454, the lowest in the series.
20-08
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format · 20 days late
2024
23-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 23 days late
2023
02-08
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format · 2 days late
2022
31-12
Financial
Highest result from 2018 to 2025net €88,175 ▲42.8%
Net result €88,175, the highest in the series.
24-08
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 24 days late
2021
18-08
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format · 18 days late
2020
31-07
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
05-08
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format · 5 days late
2018
03-08
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format · 3 days late
2017
11-08
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 31 annual accounts filed, the latest 10 are here; all 31 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.